Acasă › Leucemie mieloasă acută › Kansas › Overland Park
Studii clinice pentru Leucemie mieloasă acută în Overland Park, KS
11 studii pentru Leucemie mieloasă acută caută participanți în și în jurul orașului Overland Park (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
În curs de recrutareFaza 2
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · La 3 mi distanță
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · La 3 mi distanță
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- University of Kansas Clinical Research Center, Fairway · La 3 mi distanță
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · La 3 mi distanță
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
În curs de recrutareFaza 2
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · La 3 mi distanță
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
În curs de recrutareFaza 3
- US-Kansas City KS-KUMC, Fairway · La 3 mi distanță
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
În curs de recrutareFaza 1
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- University of Kansas Clinical Research Center, Fairway · La 3 mi distanță
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
În curs de recrutareFaza 1
- The University of Kansas Medical Center Research Institute, Fairway · La 3 mi distanță
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
În curs de recrutareFaza 1
- University of Kansas, Fairway · La 3 mi distanță
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
În curs de recrutareFaza 2
- University of Kansas Cancer Center, Fairway · La 3 mi distanță
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
În curs de recrutareFaza 1
- University of Kansas Cancer Center, Fairway · La 3 mi distanță
Studii pentru Leucemie mieloasă acută în alte orașe
- Houston, TX85 studii
- New York City, NY51 studii
- Boston, MA44 studii
- Seattle, WA41 studii
- Baldwin Park, CA40 studii
- Columbus, OH35 studii
- Philadelphia, PA34 studii
- Durham, NC33 studii
- Atlanta, GA31 studii
- Tampa, FL29 studii
- Chicago, IL26 studii
- Portland, OR25 studii
Alte studii în Overland Park
- Cancer pulmonar cu celule non-pătrate16 studii
- Cancer pulmonar11 studii
- Cancer de sân10 studii
- Fibrilație atrială8 studii
- Cancer colorectal8 studii
- Obezitate7 studii
- Cancer pancreatic7 studii
- Cancer de prostată7 studii
- Melanom6 studii
- Supraponderalitate6 studii
- Cancer ovarian6 studii
- Cancer (toate tipurile)5 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.